Fosun Pharma Announces 2025Q3 Financial Results
Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First Three Quarters of 2025 SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- On October 28, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; SSE: 600196, HKEX: 02196), a leading innovation-driven global healthcare company, announced its financial results for the first...
South Korea’s Leading Hair Loss Treatment Company, AESMED Co., Ltd., to Participate in Cosmoprof Asia Hong Kong 2025
AESMED to Focus on Promoting the 1111 Hair Care Day Campaign SEOUL, South Korea, Oct. 28, 2025 /PRNewswire/ -- AESMED Co., Ltd., a leading hair loss treatment company in South Korea, announced its participation in Cosmoprof Asia Hong Kong 2025, the largest B2B international beauty trade fair in Asia, to be held from November 12–14, 2025, at the...
Myrio Therapeutics Announces Collaboration with Leading Research Institutions to Advance Solid Tumor T cell Immunotherapeutics
Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to accelerate the development of next-generation T cell immunotherapies Partnership with T cell experts Daniel J Powell Jr., PhD, and Mark Yarmarkovich, PhD PHILADELPHIA, NEW YORK and MELBOURNE, Australia, Oct. 28, 2025 /PRNewswire/...
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health
SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced it has signed two strategic memoranda of understanding (MoUs) with NEOM, the sustainable region under development in northwest Saudi Arabia and the Ministry of Health of the Kingdom of Saudi Arabia (MOH). WuXi AppTec and NEOM have agreed to collaborate...
Xinhua Silk Road: Innovation, tradition deeply integrated on TCM trade fair in China’s Zhangshu City
BEIJING, Oct. 28, 2025 /PRNewswire/ -- China's Zhangshu City, a famed industrial hub of traditional Chinese medicine (TCM) for centuries, has actively promoted integration of tradition and innovation for China's traditional medicines and medical treatment on its annual TCM fair. The 56th National Medicinal Materials and Pharmaceuticals Trade Fair, which was held on October...
Samsung Biologics reports third quarter 2025 financial results
Recorded Q3'25 consolidated revenue of KRW 1,660.2 billion Recorded Q3'25 consolidated operating profit of KRW 728.8 billion Delivered consistent performance through stable capacity ramp-up and strengthened global partnerships INCHEON, South Korea, Oct. 28, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced its financial...
Xinhua Silk Road: Traditional Chinese medicine showcases its timeless magic
BEIJING, Oct. 28, 2025 /PRNewswire/ -- Under the night sky, Yongde Road Pedestrian Street is exceptionally bustling, where a vibrant Traditional Chinese Medicine (TCM) night market is unfolding. Niladri, an international student from Bangladesh studying at Shanghai Jiao Tong University, had an immersive experience of TCM culture. This whole-night experience completely refreshed his perception of TCM. ...
Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Fast Track Designation by FDA for the Treatment of PROC
SUZHOU, China, Oct. 28, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of advanced or metastatic platinum-resistant recurrent epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer (PROC), not restricted by...
JSBio Strengthens Commitment to Power Cellular Agriculture Commercialization
Building on biopharma expertise, JSBio drives scalable innovation and partnerships to advance the cellular agriculture industry. SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- JSBio, a leading cell culture media manufacturer and service provider in the APAC region, is deepening its commitment to cellular agriculture to accelerate the industry's path toward industrialization and sustainability. "Cellular agriculture is a breakthrough technology that...
Onward Therapeutics Exercises Exclusive Option and Signs Worldwide License Agreement with Institut du Cancer de Montpellier for Novel Onco-Metabolism Program
EPALINGES, Switzerland, Oct. 28, 2025 /PRNewswire/ -- Onward Therapeutics SA, a clinical stage oncology company, today announced that its French subsidiary, Onward Therapeutics France, has exercised its exclusive option and entered into a worldwide license agreement with Institut du Cancer de Montpellier (ICM), France, to further advance a breakthrough program in onco-metabolism. This...
